BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29032616)

  • 1. A survey on hematology-oncology pediatric AIEOP centres: The challenge of posterior reversible encephalopathy syndrome.
    Zama D; Gasperini P; Berger M; Petris M; De Pasquale MD; Cesaro S; Guerzoni ME; Mastrodicasa E; Savina F; Ziino O; Kiren V; Muggeo P; Mura RM; Melchionda F; Zanazzo GA;
    Eur J Haematol; 2018 Jan; 100(1):75-82. PubMed ID: 29032616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posterior reversible encephalopathy syndrome in pediatric patients: pathophysiology, diagnosis, and management.
    Ghali MGZ; Davanzo J; Leo M; Rizk E
    Leuk Lymphoma; 2019 Oct; 60(10):2365-2372. PubMed ID: 31556774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior Reversible Encephalopathy Syndrome in Pediatric Hematopoietic Stem Cell Transplantation with Beta Major Thalassemia: The Association between the PRES Occurrence and Class of Beta Major Thalassemia.
    Jafari L; Behfar M; Tabatabaie S; Karamlou Y; Kashani H; Radmard AR; Mohseni R; Naji P; Ghanbari F; Ashkevari P; Fakhr H; Mohammadi S; Hamidieh AA
    Clin Transplant; 2024 Jan; 38(1):e15164. PubMed ID: 37847603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Utility of Computed Tomography and Magnetic Resonance Imaging for Diagnosis of Posterior Reversible Encephalopathy Syndrome after Stem Cell Transplantation in Children and Adolescents.
    Dandoy CE; Linscott LL; Davies SM; Leach JL; Myers KC; El-Bietar J; Chima RS; Pate A; Nelson A; Wallace G; Wong HR; Jodele S
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2028-32. PubMed ID: 26226408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease.
    Anastasopoulou S; Eriksson MA; Heyman M; Wang C; Niinimäki R; Mikkel S; Vaitkevičienė GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Harila-Saari A; Ranta S
    Pediatr Blood Cancer; 2019 May; 66(5):e27594. PubMed ID: 30592147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome after pediatric heart transplantation: Increased risk for children with preexisting Glenn/Fontan physiology.
    Eilers B; Albers E; Law Y; McMullan DM; Shaw D; Kemna M
    Pediatr Transplant; 2016 Jun; 20(4):552-8. PubMed ID: 27139146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior Reversible Encephalopathy Syndrome: Risk Factors and Impact on the Outcome in Children With Acute Lymphoblastic Leukemia Treated With Nordic Protocols.
    Banerjee JS; Heyman M; Palomäki M; Lähteenmäki P; Arola M; Riikonen PV; Möttönen MI; Lönnqvist T; Taskinen MH; Harila-Saari AH
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):e13-e18. PubMed ID: 29200159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status epilepticus as a main manifestation of posterior reversible encephalopathy syndrome after pediatric hematopoietic stem cell transplantation.
    Cordelli DM; Masetti R; Bernardi B; Barcia G; Gentile V; Biagi C; Prete A; Pession A; Franzoni E
    Pediatr Blood Cancer; 2012 May; 58(5):785-90. PubMed ID: 21990274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging findings of posterior reversible encephalopathy syndrome (PRES) following haematopoietic stem cell transplantation in paediatric recipients.
    Atça AÖ; Erok B; Aydoğdu S
    BMC Pediatr; 2021 Oct; 21(1):445. PubMed ID: 34629063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posterior reversible encephalopathy syndrome (PRES): a rare condition after resection of posterior fossa tumors: two new cases and review of the literature.
    González Quarante LH; Mena-Bernal JH; Martín BP; Ramírez Carrasco M; Muñoz Casado MJ; Martínez de Aragón A; de las Heras RS
    Childs Nerv Syst; 2016 May; 32(5):857-63. PubMed ID: 26584552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posterior Reversible Encephalopathy Syndrome After Transplantation: a Review.
    Chen S; Hu J; Xu L; Brandon D; Yu J; Zhang J
    Mol Neurobiol; 2016 Dec; 53(10):6897-6909. PubMed ID: 26666662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRES in Children Undergoing Hematopoietic Stem Cell or Solid Organ Transplantation.
    Masetti R; Cordelli DM; Zama D; Vendemini F; Biagi C; Franzoni E; Pession A
    Pediatrics; 2015 May; 135(5):890-901. PubMed ID: 25917987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia during remission induction chemotherapy: a single-center retrospective study.
    Lin W; Xie J; Zhang J; Cheng H; Cui H; Zhang Y; Wu Y; Yu J; Qi P; Fan J; Gao H; Wang F; Zhang R; Zheng H
    Minerva Pediatr (Torino); 2023 Dec; 75(6):808-816. PubMed ID: 31729207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and utility assessment of posterior reversible encephalopathy syndrome early warning scoring (PEWS) scale establishment and utility assessment of PEWS scale.
    Zou LP; Liu LY; Li H; Wang YY; Liu Y; Chen J; Hu LY; Liu MJ; Zhang MN; Lu Q; Ma SF
    BMC Neurol; 2019 Feb; 19(1):30. PubMed ID: 30791893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomes.
    Chen Q; Zhao X; Fu HX; Chen YH; Zhang YY; Wang JZ; Wang Y; Wang FR; Mo XD; Han W; Chen H; Chang YJ; Xu LP; Liu KY; Huang XJ; Zhang XH
    Bone Marrow Transplant; 2020 Oct; 55(10):2035-2042. PubMed ID: 32305999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of Posterior Reversible Encephalopathy Syndrome in Children With Acute Lymphoblastic Leukemia After Induction Chemotherapy.
    Tang JH; Tian JM; Sheng M; Hu SY; Li Y; Zhang LY; Gu Q; Wang Q
    J Child Neurol; 2016 Mar; 31(3):279-84. PubMed ID: 26060305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterior Reversible Encephalopathy Syndrome in Childhood Hematological/Oncological Diseases: Multicenter Results.
    Bilir ÖA; Dikme G; Malbora B; Evim MS; Siviş ZÖ; Tüfekçi Ö; Bahadir A; Karaman S; Vural S; Bayhan T; Yarali HN; Celkan T; Özbek NY
    J Pediatr Hematol Oncol; 2021 May; 43(4):e462-e465. PubMed ID: 33060391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study.
    Kamiya-Matsuoka C; Paker AM; Chi L; Youssef A; Tummala S; Loghin ME
    J Neurooncol; 2016 May; 128(1):75-84. PubMed ID: 26900076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging Findings in Pediatric Posterior Reversible Encephalopathy Syndrome (PRES): 5 Years of Experience From a Tertiary Care Center in India.
    Gupta V; Bhatia V; Khandelwal N; Singh P; Singhi P
    J Child Neurol; 2016 Aug; 31(9):1166-73. PubMed ID: 27071468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in children with PRES and hematologic diseases.
    Tambasco N; Mastrodicasa E; Salvatori C; Mancini G; Romoli M; Caniglia M; Calabresi P; Verrotti A
    Acta Neurol Scand; 2016 Dec; 134(6):474-483. PubMed ID: 26876986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.